To evaluate the likelihood of NAFLD, a disease characterized by the accumulation of excess fat in liver cells, we assessed the expression levels of the genes CD36, FASN, and ACACA which are associated with lipid utilization in the liver. Here, FASN is linked to metabolic dysfunction-associated steatotic liver disease.